Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Nationwide Children's Hospital
Nationwide Children's Hospital
Mayo Clinic
Brigham and Women's Hospital
University of California, San Francisco
Wake Forest University Health Sciences
University Hospital, Grenoble
University of Pittsburgh
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vanderbilt-Ingram Cancer Center
Washington University School of Medicine
University of Pittsburgh